Suppression of the Immune Response Against Exogenous Desmoglein 3 in Desmoglein 3 Knockout Mice: An Implication for Gene Therapy
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (4) , 610-615
- https://doi.org/10.1046/j.1523-1747.2003.12090.x
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 38 references indexed in Scilit:
- Immunologic and Histopathologic Characterization of an Active Disease Mouse Model for Pemphigus VulgarisJournal of Investigative Dermatology, 2002
- Genetic Correction of Inherited Epidermal DisordersHuman Gene Therapy, 2000
- The Genodermatoses: Candidate Diseases for Gene TherapyHuman Gene Therapy, 2000
- Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epitheliaGene Therapy, 1998
- CD40 is functionally expressed on human keratinocytesEuropean Journal of Immunology, 1996
- Cytokine gene expression in epidermis with biological effects following injection of naked DNANature Genetics, 1995
- Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responsesEuropean Journal of Immunology, 1995
- Epidermis: An Attractive Target Tissue for Gene TherapyJournal of Investigative Dermatology, 1994
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994
- Correction of Steroid Sulfatase Deficiency by Gene Transfer into Basal Cells of Tissue-Cultured Epidermis from Patients with Recessive X-Linked IchthyosisExperimental Cell Research, 1993